In other words, the findings may reveal new avenues towards the treatment of skeletal muscle atrophy caused by mitochondrial ...

The team is excited about their new findings and the significant potential it has in developing new treatments for age-related muscle atrophy along with other health condition related to impaired ...

Um, there are now two approved treatments for our patients with spinal muscular atrophy. One of them is a gene therapy treatment, um, and the thought of it is that if you are able to intervene ...

The team is excited about their new findings and the significant potential it has in developing new treatments for ...

There is some debate as to whether GLP-1 agonist drugs like Wegovy can lead to unhealthy muscle mass loss in addition to ...

The New Haven, Conn., biopharmaceutical company said Monday that taldefgrobep had shown clinically meaningful improvements in motor function in spinal muscular atrophy patients, but the treatment arm ...

By Mariam Sunny (Reuters) -Biohaven said on Monday its experimental treatment for a rare neuromuscular disorder failed to ...

We all age. And while humanity's life expectancy has increased dramatically in the modern era, we still struggle with the ...

The cardiomyocyte area of mice without semaglutide treatment (left) and with semaglutide treatment (right ... The means they ...

Despite disappointing results in the genetic neurodegenerative disorder, the drug shows potential for treating obesity.